Valeant Pharmaceuticals reported $5.45B in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US $ 19099M 2200M
Ani Pharmaceuticals ANIP:US $ 191.8M 9M
Aphria Inc APH:CN C$ 730.7M 38.56M
Aurora Cannabis Inc ACB:CN 665.89M 108.33M
Biogen BIIB:US $ 7162.3M 21.4M
Bristol Myers Squibb BMY:US $ 29161M 2050M
Canopy Growth Corp WEED:CN C$ 2.68B 163.02M
Catalent CTLT:US $ 2918M 143.5M
Corcept Therapeutics CORT:US $ 411.27M 1.65M
Danaher DHR:US $ 10776M 4616M
Drreddys Laboratories RDY:US $ 158776M 10527M
Eli Lilly And LLY:US $ 17295.5M 691M
Endo International Ordinary Shares ENDP:US $ 2569.33M 74.1M
Gilead Sciences GILD:US $ 14498M 1220M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Horizon Pharma HZNP:US $ 2175.38M 344.01M
JAZZ PHA JAZZ:US $ 2953.96M 212.93M
Lannett LCI:US $ 353.56M 16.35M
Nektar Therapeutics NKTR:US $ 1056.15M 42.9M
Pacira Pharmaceuticals PCRX:US $ 792.58M 72.33M
Perrigo Ordinary Shares PRGO:US $ 4420.2M 68.4M
Phibro Animal Health PAHC:US $ 498.91M 27.19M
Prestige Brands PBH:US $ 408.52M 138.69M
Revance Therapeutics RVNC:US $ 354.6M 51.82M
Supernus Pharmaceuticals SUPN:US $ 639.24M 53.22M
Valeant Pharmaceuticals VRX:CN $ 5450M 58M
Vertex Pharmaceuticals VRTX:US $ 8457.51M 81.79M
Zoetis ZTS:US $ 7048M 254M